Codiak BioSciences, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Codiak BioSciences, Inc. had Deferred Tax Assets, Operating Loss Carryforwards of $51.67 million as of 2021-12-31, per its 10-K filed 2022-03-10.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2022-03-10
- 2021-12-31: Deferred Tax Assets, Operating Loss Carryforwards $51.67M.
- 2020-12-31: Deferred Tax Assets, Operating Loss Carryforwards $37.61M.
- 2019-12-31: Deferred Tax Assets, Operating Loss Carryforwards $21.50M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2021-12-31 | $51.67M 10-K · filed 2022-03-10 |
| 2020-12-31 | $37.61M 10-K · filed 2022-03-10 |
| 2019-12-31 | $21.50M 10-K · filed 2021-03-17 |